DIMENHYDRINATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for dimenhydrinate and what is the scope of patent protection?

Dimenhydrinate is the generic ingredient in one branded drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, Watson Labs, Watson Labs Teva, Wyeth Ayerst, Alra, Heather, and Nexgen Pharma Inc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dimenhydrinate. One supplier is listed for this compound.

Summary for DIMENHYDRINATE

US Patents:	0
Tradenames:	1
Applicants:	8
NDAs:	9
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	72
Clinical Trials:	21
Patent Applications:	6,731
Drug Prices:	Drug price trends for DIMENHYDRINATE
What excipients (inactive ingredients) are in DIMENHYDRINATE?	DIMENHYDRINATE excipients list
DailyMed Link:	DIMENHYDRINATE at DailyMed

See drug prices for DIMENHYDRINATE

Recent Clinical Trials for DIMENHYDRINATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
The University of The West Indies	Early Phase 1
IWK Health Centre	Phase 4
Ciusss de L'Est de l'Île de Montréal	N/A

See all DIMENHYDRINATE clinical trials

Medical Subject Heading (MeSH) Categories for DIMENHYDRINATE

Antiemetics
Histamine H1 Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for DIMENHYDRINATE

R06AA	Aminoalkyl ethers
R06A	ANTIHISTAMINES FOR SYSTEMIC USE
R06	ANTIHISTAMINES FOR SYSTEMIC USE
R	Respiratory system

US Patents and Regulatory Information for DIMENHYDRINATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	DIMENHYDRINATE	dimenhydrinate	TABLET;ORAL	085166-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Ayerst	DIMENHYDRINATE	dimenhydrinate	INJECTABLE;INJECTION	084316-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare	DIMENHYDRINATE	dimenhydrinate	INJECTABLE;INJECTION	084767-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.